<?xml version="1.0" encoding="iso-8859-1" ?>
<newsitem itemid="22169" id="root" date="1996-08-29" xml:lang="en">
<title>USA: Ventana Medical Q2 shr loss narrows.</title>
<headline>Ventana Medical Q2 shr loss narrows.</headline>
<dateline>TUCSON, Ariz. 1996-08-29</dateline>
<text>
<p>VENTANA MEDICAL SYSTEMS, INC.</p>
<p>		 PRO FORMA CONSOLIDATED STATEMENTS OF OPERATIONS</p>
<p>			(in thousands, except per share data)</p>
<p>					(Unaudited)</p>
<p>			Three Months Ended	 Six Months Ended</p>
<p>				    June 30,		   June 30,</p>
<p>			   1995	  1996	  1995	1996</p>
<p>    Net Sales	$4,616	$5,541	$9,049   $10,789</p>
<p>Cost of goods sold</p>
<p>			  2,243	 2,129	 4,448     4,053</p>
<p>    Total	     2,373	 3,412	 4,601     6,716</p>
<p>Operating expenses:</p>
<p>Research and development</p>
<p>			    721	   754	 2,551     1,525</p>
<p>Selling, general and</p>
<p>	  administrative</p>
<p>			  2,821	 2,994	 5,402     5,793</p>
<p>Nonrecurring expenses</p>
<p>			    190	   212	   656	 212</p>
<p>Amortization of intangibles</p>
<p>			     63	   134	   146	 273</p>
<p>Loss from operations</p>
<p>			(1,422)	 (682)     (4,154)   (1,087)</p>
<p>Interest income (expense)</p>
<p>			  (207)	  (61)	 (862)	(66)</p>
<p>    Net loss     ($1,629)	($743)    ($5,016)  ($1,153)</p>
<p>Net loss per share, as adjusted</p>
<p>(Note 1 and 2)</p>
<p>			($0.19)     ($0.08)     ($0.58)   ($0.13)</p>
<p>Shares used in computing</p>
<p>net loss per share</p>
<p>		    8,650,568   9,137,369   8,589,666 8,996,063</p>
<p>Note 1:  On July 26, 1996, the Company sold, through an underwritten initial public offering, 1,890,907 shares of its Common Stock at $10.00 per share.  Upon closing of the Company's initial public offering, all outstanding shares of its Series A, C and D Redeemable Convertible Preferred stock were converted into 6,716,997 shares of Common Stock, after giving affect to the Company's 1 for 2.7059046 reverse stock split effected in July 1996.  The unaudited Pro Forma Consolidated Balance Sheet at June 30, 1996 and unaudited Pro Forma Consolidated Statement of Cash Flow for the six months ended June 30, 1996 reflect the impact of the initial public offering, the conversion of the Redeemable Convertible Preferred stock and the repayment of $2.0 million in bank term notes as if they had occurred as of June 30, 1996.  All shares and per share amounts have been retroactively adjusted to reflect the reverse stock split.</p>
<p>Net Loss Per Share:</p>
<p>Note 2:  Net loss per share is computed using the weighted average number of shares of common stock outstanding.</p>
</text>
<copyright>(c) Reuters Limited 1996</copyright>
<metadata>
<codes class="bip:countries:1.0">
  <code code="USA">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1996-08-29"/>
  </code>
</codes>
<codes class="bip:industries:1.0">
  <code code="I37200">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1996-08-29"/>
  </code>
</codes>
<codes class="bip:topics:1.0">
  <code code="C15">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1996-08-29"/>
  </code>
  <code code="C151">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1996-08-29"/>
  </code>
  <code code="CCAT">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1996-08-29"/>
  </code>
</codes>
<dc element="dc.date.created" value="1996-08-29"/>
<dc element="dc.publisher" value="Reuters Holdings Plc"/>
<dc element="dc.date.published" value="1996-08-29"/>
<dc element="dc.source" value="Reuters"/>
<dc element="dc.creator.location" value="TUCSON, Ariz."/>
<dc element="dc.creator.location.country.name" value="USA"/>
<dc element="dc.source" value="Reuters"/>
</metadata>
</newsitem>
